A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Coronaviruses are a genetically diverse family of viruses that infect birds and mammals, with most coronavirus strains limited to infecting only certain hosts. Human coronaviruses, for example, cause up to 30 percent of common colds.
In the last 15 years, however, coronaviruses have demonstrated their ability to jump into new species. Zoonotic (animal) coronaviruses have infected humans, causing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe diseases with high mortality rates ranging from 10 percent for SARS to 40 percent for MERS. The MERS-coronavirus continues to cause new infections in the Middle East.
“There’s a real concern that the MERS coronavirus could escape broadly when millions of people visit Saudi Arabia for the Hajj,” said Mark Denison, M.D., Craig-Weaver Professor of Pediatrics and professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.
But to date, there has been no effective antiviral drug for any known coronavirus, Denison noted.
Denison and his team at Vanderbilt have studied the basic biology of coronaviruses for more than 20 years. In an effort to find chemical tools that would allow them to probe viral replication, graduate student Brett Case screened a series of compounds selected and provided by Gilead Sciences.
Case demonstrated that one of the compounds was highly active against coronaviruses in cultured cells. The finding was a surprise, Denison said, because compounds in the same class (nucleoside analogs) have normally failed to inhibit coronavirus replication.
The compound, called GS-5734, is currently in clinical development for treatment of Ebola virus disease.
Denison’s longtime collaborator Ralph Baric, Ph.D., at the University of North Carolina and his team demonstrated that GS-5734 inhibits SARS-coronavirus and MERS-coronavirus replication in multiple in vitro systems, including cultures of primary human airway epithelial cells, which are the cells infected by respiratory coronaviruses.
The researchers also showed that GS-5734 was effective against a circulating human coronavirus, bat coronaviruses, and bat coronaviruses that are considered “prepandemic” because they can infect cultured human cells.
Using a mouse model of SARS, the investigators demonstrated that both prophylactic (before infection) and early therapeutic (soon after infection) administration of GS-5734 reduced viral load in the lungs and improved respiratory functions.
“This compound shows broad activity against a variety of human and animal coronaviruses and represents an exciting potential therapeutic for a family of viruses prone to emergence from animal reservoirs,” Denison said.
Denison and his team at Vanderbilt will continue to use the compound “as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses,” he said.
“This is an exciting example of how pursuing fundamental research to understand the mechanisms of virus replication and pathogenesis can lead to an important compound with therapeutic potential.”
The Latest on: Coronaviruses
- Aishwarya Rai Bachchan tests positive for coronaviruson July 12, 2020 at 4:12 am
India actor’s results follow admission to hospital of father-in-law Amitabh Bachchan and husband ...
- What it's like to perform 'La traviata' live for an audience in the age of coronaviruson July 12, 2020 at 3:43 am
Performers Matthew Polenzani and Michael Fabiano describe performing at Teatro Real in a socially distanced opera performance amid coronavirus.
- US Covid-19 cases are climbing but some state and local leaders are clashing over moves to curb the spreadon July 12, 2020 at 3:33 am
With coronavirus cases climbing across the US, local and state leaders have found themselves at odds over the types of restrictions that should be in place to move forward effectively.
- Coronavirus: I trust people's sense on face masks - Goveon July 12, 2020 at 3:28 am
Senior minister Michael Gove has said he does not think face coverings should be compulsory in shops in England, saying he trusts people's "good sense". It is understood ministers are considering ...
- As Covid-19 Vaccine Development Pushes Ahead, Researchers Probe Safetyon July 12, 2020 at 2:42 am
The final-stage trials for a coronavirus vaccine starting to get under way will look for a rare side effect that could worsen the disease the inoculation is supposed to protect against.
- Do You Dare Switch Jobs in the Coronavirus Economy?on July 12, 2020 at 2:38 am
Workers debating a change sweat their security and how to make a good impression with new colleagues while many are still in lockdown.
- Love in the time of coronavirus: Couples share how they found matches in the middle of a pandemicon July 12, 2020 at 2:09 am
He went on one Facetime date -- the girl, he said, seemed like she was "just going through her matches ... like on a spreadsheet." But on May 29, he had plans to meet up with a different match -- this ...
- Indonesia reports 1,681 new coronavirus cases - Health Ministry officialon July 12, 2020 at 2:04 am
Indonesia reported 1,681 new coronavirus cases on Sunday, bringing the total count to 75,699, Health Ministry official Achmad Yurianto told a televised news briefing.
- As India Struggles With Coronavirus, Bollywood’s Biggest Star Tests Positiveon July 12, 2020 at 1:56 am
Amitabh Bachchan, a revered celebrity whose face is everywhere in India, checked into a hospital on Saturday, prompting countless Indians to pray for him.
- Safety First for Spaniards Voting Amid New Coronavirus Outbreakson July 12, 2020 at 1:50 am
Authorities have said more than 460 people across the two regions who recently tested positive for the coronavirus will be unable to vote. People awaiting test results are also ba ...
via Google News and Bing News